Scholar Rock Holding Corp
SRRK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001727196
In the last 90 days, Scholar Rock Holding Corp insiders filed 0 open-market purchases and 5 sales; 306 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Scholar Rock Holding Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 90
- −10 vs. Q3 2021
- Shares held
- 29.7M
- +840.2K (+2.9%) vs. Q3 2021
- Total value
- $738.8M
- −$213.6M (−22.4%) vs. Q3 2021
- New holders
- 9
- 36 more added
- Sold out
- 19
- 24 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRRK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 306 | $7.63B |
| Q1 2026 | 274 | $6.53B |
| Q4 2025 | 274 | $5.44B |
| Q3 2025 | 241 | $4.32B |
| Q2 2025 | 236 | $3.89B |
| Q1 2025 | 231 | $3.42B |
| Q4 2024 | 224 | $4.51B |
| Q3 2024 | 161 | $710.2M |
| Q2 2024 | 166 | $712.1M |
| Q1 2024 | 161 | $1.51B |
| Q4 2023 | 133 | $1.52B |
| Q3 2023 | 89 | $382.7M |
| Q2 2023 | 85 | $386.3M |
| Q1 2023 | 87 | $374.1M |
| Q4 2022 | 82 | $410.2M |
| Q3 2022 | 85 | $313.1M |
| Q2 2022 | 83 | $248.6M |
| Q1 2022 | 94 | $402.2M |
| Q4 2021 | 90 | $738.8M |
| Q3 2021 | 101 | $952.5M |
| Q2 2021 | 105 | $825.5M |
| Q1 2021 | 124 | $1.41B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Scholar Rock Holding Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Welch & Forbes LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −6,683−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −6,199−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −6,093−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −1,170−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −790−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| First Mercantile Trust Co | – | – | – | – | Not filed |